In the present study, we analyzed the expression of DNM3 in CRC tissue samples and para-cancer tissue samples and its correlation with clinicopathological characteristics, and evaluated its potential clinical value in CRC based on previous studies, in the hope of providing new ideas for the diagnosis and/or treatment of CRC. Here, DNM3 is linked to colorectal carcinoma.